Paper8494366
Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.
Kadurugamuwa JL and 2 others. Antimicrob Agents Chemother, 1993. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect. Papers, record 8494366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8494366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gentamicins | Major topic |
| Lipopolysaccharides | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Blotting, Western | |
| Cell Membrane | |
| Electrophoresis, Polyacrylamide Gel | |
| Muramidase | |
| Silver Staining |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4313132 | Role of divalent cations in the action of polymyxin B and EDTA on Pseudomonas aeruginosa. | J Gen Microbiol | 1969 | https://conductscience.org/library/papers/4313132 | PubMed |
| 2 | 14450178 | Kinetics of loss of vibility of Escherichia coli exposed to streptomycin. | J Bacteriol | 1962 | https://conductscience.org/library/papers/14450178 | PubMed |
| 3 | 820248 | Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/820248 | PubMed |
| 4 | 97259 | Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/97259 | PubMed |
| 5 | 110433 | The extraction and analysis of lipopolysaccharides from Pseudomonas aeruginosa strain PAO, and three rough mutants. | Can J Microbiol | 1979 | https://conductscience.org/library/papers/110433 | PubMed |
| 6 | 118160 | Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins. | J Bacteriol | 1979 | https://conductscience.org/library/papers/118160 | PubMed |
| 7 | 7446125 | Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre. | Acta Pathol Microbiol Scand B | 1980 | https://conductscience.org/library/papers/7446125 | PubMed |
| 8 | 6268456 | Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. | FEBS Lett | 1981 | https://conductscience.org/library/papers/6268456 | PubMed |
| 9 | 6176137 | A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. | Anal Biochem | 1982 | https://conductscience.org/library/papers/6176137 | PubMed |
| 10 | 6803667 | Chemical and chromatographic analysis of lipopolysaccharide from an antibiotic-supersusceptible mutant of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6803667 | PubMed |
| 11 | 6293694 | Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism. | Can J Microbiol | 1982 | https://conductscience.org/library/papers/6293694 | PubMed |
| 12 | 6187729 | Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. | J Bacteriol | 1983 | https://conductscience.org/library/papers/6187729 | PubMed |
| 13 | 6302204 | Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1. | J Gen Microbiol | 1983 | https://conductscience.org/library/papers/6302204 | PubMed |
| 14 | 6405665 | The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. | Am Rev Respir Dis | 1983 | https://conductscience.org/library/papers/6405665 | PubMed |
| 15 | 6351731 | Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6351731 | PubMed |
| 16 | 6413410 | Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. | Infect Immun | 1983 | https://conductscience.org/library/papers/6413410 | PubMed |
| 17 | 6197737 | Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6197737 | PubMed |
| 18 | 6207771 | Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6207771 | PubMed |
| 19 | 6436396 | Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic. | J Infect Dis | 1984 | https://conductscience.org/library/papers/6436396 | PubMed |
| 20 | 6093683 | Alterations in outer membrane permeability. | Annu Rev Microbiol | 1984 | https://conductscience.org/library/papers/6093683 | PubMed |
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41614127 | Glutamate potentiates susceptibility of P. aeruginosa clinical isolates to gentamycin: a new adjuvant hope for an old antibiotic. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41614127 | PubMed |
| 38954678 | The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures. | PLoS Biol | 2024 | https://conductscience.org/library/papers/38954678 | PubMed |
| 38736943 | Increased antibiotic resistance of Pseudomonas aeruginosa isolates from chronic rhinosinusitis patients grown in anaerobic conditions. | Laryngoscope Investig Otolaryngol | 2024 | https://conductscience.org/library/papers/38736943 | PubMed |
| 38501368 | In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/38501368 | PubMed |
| 37533213 | Illuminating the oral microbiome: cellular microbiology. | FEMS Microbiol Rev | 2023 | https://conductscience.org/library/papers/37533213 | PubMed |
| 37223363 | Antibiotic tolerance in environmentally stressed Bacillus subtilis: physical barriers and induction of a viable but nonculturable state. | Microlife | 2022 | https://conductscience.org/library/papers/37223363 | PubMed |
| 35341941 | Identifying targets to prevent aminoglycoside ototoxicity. | Mol Cell Neurosci | 2022 | https://conductscience.org/library/papers/35341941 | PubMed |
| 34827367 | Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34827367 | PubMed |
| 34439073 | Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring blaNDM-1 and blaNDM-5. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34439073 | PubMed |
| 32457248 | Parallel Evolution of Tobramycin Resistance across Species and Environments. | mBio | 2020 | https://conductscience.org/library/papers/32457248 | PubMed |
| 31861540 | The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology. | Pathogens | 2019 | https://conductscience.org/library/papers/31861540 | PubMed |
| 31781056 | Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31781056 | PubMed |
| 31540233 | Silk-Based Therapeutics Targeting Pseudomonas aeruginosa. | J Funct Biomater | 2019 | https://conductscience.org/library/papers/31540233 | PubMed |
| 30837659 | Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins. | Sci Rep | 2019 | https://conductscience.org/library/papers/30837659 | PubMed |
| 30688634 | Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation. | J Med Microbiol | 2019 | https://conductscience.org/library/papers/30688634 | PubMed |
| 29463528 | Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29463528 | PubMed |
| 29339388 | Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29339388 | PubMed |
| 29039211 | Synergistic effects of heat and antibiotics on Pseudomonas aeruginosa biofilms. | Biofouling | 2017 | https://conductscience.org/library/papers/29039211 | PubMed |
| 28993331 | Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28993331 | PubMed |
| 28893782 | Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28893782 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8494366
GET https://conductscience.org/api/papers/v1/8494366/references?page=2